29 results
Thumbnail

D1.13 - A rare case of isolated histaminergic angioedema

Thumbnail

D1.15 - True Mugwort Sensitization Presenting as Severe Atopic Dermatitis: A Diagnostic Challenge

Thumbnail

D1.02 - Sensitization to Sesame Proteins Despite Negative Conventional Testing

Thumbnail

D1.03 - Identification of a Thaumatin-Like Protein as a Shared Allergen in Kiwi and Persimmon: Molecular Analysis in a Case of Anaphylaxis

Thumbnail

D1.08 - Clinical relevance of troponin C (Cra c 6) sensitization in crustacean allergy

Thumbnail

D1.10 - Underrecognition of Anaphylaxis in Children: Gaps in Diagnosis and Management

Thumbnail

D1.11 - Determinants of allergen sensitization and wheal size variability in skin prick testing in a large outpatient cohort

Thumbnail

D1.14 - Biphasic, Refractory, and Persistent Anaphylaxis in Children

Thumbnail

D1.06 - When an alergic reaction turns into a cardiac event: clinical characterization of Kounis Syndrome

Thumbnail

D1.372 - Transition to SCIG as an Alternative in Patients with Cytokine Storm from IVIG

Thumbnail

D1.374 - Genetic susceptibility to radiocontrast media-induced anaphylaxis: A microarray gene chip study in a Korean population

Thumbnail

D1.365 - Long-term course of NSAID tolerance in patients with cross-hypersensitivity presenting with respiratory symptoms

Thumbnail

D1.367 - Risk factors for immediate hypersensitivity reactions to rituximab

Thumbnail

D1.373 - Hypersensitivity to Biologic Therapies: Mechanism of Cross-reactivity

Thumbnail

D1.376 - Successful Desensitization with Temozolomide in a Patient with a Hypersensitivity Reaction to Temozolomide

Thumbnail

D1.377 - Folic Acid Allergy: A Rare Case

Thumbnail

D1.378 - Hypersensitivity During Continuous 5-Fluorouracil Infusion: Two Cases Successfully Managed With Desensitization

Thumbnail

- D1.524 - StingReady: a safe and alternative method for controlled sting challenge tests

Thumbnail

- D1.515 - Occupational Exposure of Patients Allergic to Hymenoptera Venom

Thumbnail

- D1.516 - Compliance with hymenoptera venom inmunotherapy (VIT)